Validation of the Korean version of the EORTC QLQ-C30

被引:299
作者
Yun, YH
Park, YS
Lee, E
Bang, SM
Heo, DS
Park, SY
You, CH
West, K
机构
[1] Natl Canc Ctr, Res Inst & Hosp, Goyang Si 441764, Gyeonggi Do, South Korea
[2] Gachon Med Sch, Dept Internal Med, Inchon, South Korea
[3] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[4] EORTC Qual Life Unit, Brussels, Belgium
关键词
BDI; BPI; EORTC QLQ-C30; Korea; validation study;
D O I
10.1023/B:QURE.0000021692.81214.70
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study evaluated the Korean version of the EORTC QLQ-C30 (version 3.0) in terms of psychometric properties and its validation. One hundred and seventy patients completed three questionnaires EORTC QLQ-C30, the Beck depression inventory (BDI), and a brief pain inventory (BPI). Multitrait scaling analyses demonstrated that all scales met multidimensional conceptualization criteria, in terms of convergence and discrimination validity. Cronbach's alpha coefficients for eight multiple-item scales were greater than 0.70, with the exception of cognitive functioning. All interscale correlations were statistically significant in the expected direction ( p < 0.01). Multivariate analyses showed that physical and emotional functioning were significant explanatory variables for the global quality-of-life (QOL) scale (regression coefficients: 0.36, p < 0.001; and 0.37, p < 0.001; respectively). All scales were significantly associated with pain severity and interference of the BPI, and with the cognitive-affective and somatic scales of the BDI. The emotional-functioning scale was substantially correlated with the cognitive-affective scale and somatic scale of the BDI. These results demonstrate that the Korean version of the EORTC QLQ-C30 is a valid instrument for evaluating Korean-speaking patients with cancer, and can be used to distinguish clearly between subgroups of patients of differing performance status.
引用
收藏
页码:863 / 868
页数:6
相关论文
共 17 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Evaluation of the EORTC QLQ-C30 questionnaire: A comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients [J].
Apolone, G ;
Filiberti, A ;
Cifani, S ;
Ruggiata, R ;
Mosconi, P .
ANNALS OF ONCOLOGY, 1998, 9 (05) :549-557
[3]  
BECH P, 1981, Acta Psychiatrica Scandinavica Supplementum, V64, P1
[4]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[5]   PAIN AND ITS TREATMENT IN OUTPATIENTS WITH METASTATIC CANCER [J].
CLEELAND, CS ;
GONIN, R ;
HATFIELD, AK ;
EDMONSON, JH ;
BLUM, RH ;
STEWART, JA ;
PANDYA, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :592-596
[6]  
Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
[7]   Relationship between quality of life and depression in patients with head and neck cancer [J].
D'Antonio, LL ;
Long, SA ;
Zimmerman, GJ ;
Peterman, AH ;
Petti, GH ;
Chonkich, GD .
LARYNGOSCOPE, 1998, 108 (06) :806-811
[8]  
Fayer P., 1995, EORTC QLQ C30 SCORIN
[9]  
Hahn YT, 1986, J Korean Neuropsychiatr Assoc, V1986, P487
[10]  
Hays R., 1988, USERS GUIDE MULTITRA